Inhibitor Therapeutics
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Inhibitor Therapeutics's balance sheet done over the years? Its assets were worth $8,949,155 last year, which is less than in the previous period. 41% of Inhibitor Therapeutics’s total assets is currently financed by debt. Its liabilities reached the amount of $3,665,164, which means an decrease by 0% compared compared to last year.
Debt to Assets
| 2014 | 462978 | 400.89K | 86.59% |
|---|---|---|---|
| 2015 | 885859 | 461.88K | 52.14% |
| 2016 | 7338095 | 308.13K | 4.2% |
| 2017 | 768052 | 601.48K | 78.31% |
| 2018 | 1233001 | 1.20M | 97.38% |
| 2019 | 899966 | 3.43M | 381.25% |
| 2020 | 131759 | 3.49M | 2650.26% |
| 2021 | 58784 | 3.67M | 6259.58% |
| 2022 | 11975124 | 3.67M | 30.72% |
| 2023 | 8949155 | 3.66M | 40.96% |
INTI Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 8.83M | 11.95M | 30.62K | 75.05K | 803.81K | 1.10M | 344.11K | 6.88M | 601.44K | 365.16K |
Short term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other current assets | 109.24K | 23.9K | 28.15K | 32.29K | 42.45K | 41.29K | 311.65K | 250K | 34.41K | 97.81K |
Total current assets | 8.94M | 11.97M | 58.78K | 107.35K | 846.26K | 1.15M | 655.76K | 7.19M | 635.85K | 462.97K |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 250K | 0 |
Other non-current assets | 0 | 0 | 0 | 24.40K | 53.7K | 82.99K | 112.28K | 141.57K | 0 | 0 |
Total non-current assets | 0 | 0 | 0 | 24.40K | 53.7K | 82.99K | 112.28K | 141.57K | 250K | 0 |
Total assets | 8.94M | 11.97M | 58.78K | 131.75K | 899.96K | 1.23M | 768.05K | 7.33M | 885.85K | 462.97K |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 3M | 115.78K | 100.82K | 3M | 500K | 0 | 0 | 0 | 0 |
Short term debt | 0 | 411K | 231K | 30.04K | -3M | -400.05K | 0 | 0 | 0 | 0 |
Total current liabilities | 665.16K | 678.78K | 679.63K | 425.40K | 431.10K | 700.65K | 601.48K | 308.13K | 461.88K | 400.89K |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | 66.55K | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 0 | 0 | 3.01M | 0 | 0 | 0 | 0 | 0 | 0 |
Total non-current liabilities | 3M | 3M | 3M | 3.06M | 3M | 500K | 534.95K | 297.82K | 383.35K | 324.96K |
Total liabilities | 3.66M | 3.67M | 3.67M | 3.49M | 3.43M | 1.20M | 601.48K | 308.13K | 461.88K | 400.89K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |